Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Approach to the Surveillance of Pre-Malignant Gastric Lesions

NCT04251403 is registered in ClinicalTrials.gov with New York Presbyterian Hospital as lead sponsor.

NCT NCT04251403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04251403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Approach to the Surveillance of Pre-Malignant Gastric Lesions
Lead sponsor
New York Presbyterian Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
February 29, 2020
Completion date
February 28, 2021
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, gastric cancer, gastric dysplasia, intestinal metaplasia of gastric mucosa